DECIPHERING THE ROLE OF PERIPHERAL AND CENTRAL NERVOUS SYSTEM METABOTROPIC GLUTA...
DECIPHERING THE ROLE OF PERIPHERAL AND CENTRAL NERVOUS SYSTEM METABOTROPIC GLUTAMATE RECEPTORS IN NEUROPHATIC PAIN WITH PHOTOACTIVABLE LIGANDS
OPTOGENETIC APPROACHES ARE VIEWED AS VERY PROMISING APPROACHES TO TACKLE PHYSIOLOGICAL PROCESSES, AND EVENTUALLY FOR SPACE AND TIME-CONTROLLED THERAPEUTIC INTERVENTIONS, HOWEVER, THE NEED FOR TRANSGENES LIMITS THE DEVELOPMENT OF T...
ver más
Fecha límite participación
Sin fecha límite de participación.
Financiación
concedida
El organismo AGENCIA ESTATAL DE INVESTIGACIÓN notifico la concesión del proyecto
el día 2013-01-01
No tenemos la información de la convocatoria
0%
100%
Información adicional privada
No hay información privada compartida para este proyecto. Habla con el coordinador.
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
PCIN-2013-017-C03-01
DECIPHERING THE ROLE OF PERIPHERAL AND CENTRAL NERVOUS SYSTE...
90K€
Cerrado
PCIN-2013-019-C03-03
DECIPHERING THE ROLE OF PERIPHERAL AND CENTRAL NERVOUS SYSTE...
70K€
Cerrado
SAF2014-59999-JIN
MAPEADO FUNCIONAL DEL CEREBRO EN MODELOS MURINOS DE AUTISMO...
204K€
Cerrado
PCIN-2015-163-C02-01
MODULADORES FOTOCONMUTABLES SINTETICOS PARA MANIPULAR REMOTA...
81K€
Cerrado
SAF2012-34991
ESTUDIO DE LA CONEXION RECEPTOR DE GLUTAMATO NMDA CON RECEPT...
152K€
Cerrado
SAF2013-44533-P
TRANSLOCACION POSTSINAPTICA DE PKC GAMMA EN LA PRESENSIBILIZ...
73K€
Cerrado
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
OPTOGENETIC APPROACHES ARE VIEWED AS VERY PROMISING APPROACHES TO TACKLE PHYSIOLOGICAL PROCESSES, AND EVENTUALLY FOR SPACE AND TIME-CONTROLLED THERAPEUTIC INTERVENTIONS, HOWEVER, THE NEED FOR TRANSGENES LIMITS THE DEVELOPMENT OF THESE APPROACHES, AN ALTERNATIVE IS BASED ON OPTOPHARMACOLOGY, WHICH CONSISTS OF USING LIGHT-ACTIVABLE COMPOUNDS THAT CAN REACH THEIR TARGET ONLY UPON LIGHT ACTIVATION, THE LIGHTPAIN PROJECT IS AIMED AT DEVELOPING PHOTO-ACTIVABLE LIGANDS TARGETING SELECTIVELY METABOTROPIC GLUTAMATE (MGLU) RECEPTORS, WHICH REPRESENT PROMISING DRUG TARGETS FOR PAIN CONTROL, THE ULTIMATE OBJECTIVES ARE DIRECTED TO UNDERSTAND THE ROLE OF THE DIFFERENT MGLU RECEPTOR SUBTYPES AT DIFFERENT SITES OF THE NERVOUS SYSTEM IN REGULATING PAIN TRANSMISSION, THESE LIGHT-CONTROLLED MOLECULES AND THE TECHNIQUES FOR OPTICAL LIGAND DELIVERY TO THE SPINAL CORD, BRAIN AND PERIPHERAL NERVES WILL BE USED TO UNDERSTAND HOW MGLU RECEPTORS CRITICALLY REGULATE PAIN THRESHOLD UNDER PATHOLOGICAL CONDITIONS, THE LIGHTPAIN PROJECT SPECIFICALLY ADDRESSES THIS ISSUE USING SUBTYPE-SELECTIVE MGLU RECEPTOR LIGANDS ( POSITIVE OR NEGATIVE ALLOSTERIC MODULATORS) THAT ARE PHOTOCHEMICALLY TRIGGERED AND CAN THEREFORE INTERACT WITH MGLU RECEPTORS ONLY AT SITES (PERIPHERAL OR CENTRAL) THAT ARE SPATIOTEMPORALLY EXPOSED TO LIGHT,